CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
000078 Shenzhen Neptunus Bioengineering
- 2.27
- +0.02+0.89%
Market Closed Apr 30 15:00 CST
5.97BMarket Cap-4.92P/E (TTM)
2.30High2.24Low136.30KlotVolume2.24Open2.25Pre Close31.01MTurnover0.52%Turnover RatioLossP/E (Static)2.63BShares3.1952wk High3.29P/B5.96BFloat Cap2.0752wk Low2.48Limit Up2.63BShs Float14.30Historical High2.03Limit Down2.67%Amplitude0.40Historical Low--Dividend TTM2.27Avg Price60.78KlotAsk--Div YieldTTM100Lot Size72.73KlotBid
Shenzhen Neptunus Bioengineering News
Kaiwang Biotech: Announcement on the 2024 write-off of bad debts and preparation for asset impairment
Neptune Biology: 2024 Annual Report
Neptune Biotech: Report for the first quarter of 2025
Haiwang Biotech: 2024 Independent Director Debriefing Report (Zhang Hua)
Neptune Biotech: Announcement of Supervisory Board Resolutions
Haiwang Biotech: Audit Opinions of the Supervisory Board on Matters Related to the 19th Meeting of the 9th Board of Supervisors
Neptune Biotech: 2024 Annual Financial Report
Haiwang Biotech: Special note by the Board of Directors on matters covered by the 2024 Unqualified Internal Control Audit Report with highlighted sections
Neptune Biotech: Internal Control Audit Report
Kaiwang Biotech: Audit Committee Report on the 2024 Performance Evaluation Report of Accounting Firms and Report on the Performance of Supervisory Duties
Neptune Biotech: Announcement on changes in accounting policies
Kaiwang Biotech: 2024 Report on the Work of the Supervisory Committee
Neptune Biology: 2024 Annual Report Summary
Neptune Biotech: Announcement on the 2024 Profit Distribution Plan
Neptune Biotech: Annual Special Audit Report on Related Party Capital Occupation
Kaiwang Biotech: Report on the 2024 Assessment Report on the Performance Status of Accounting Firms
Neptune Biotech: Announcement on the Renewal of the 2025 Audit Institution
Neptune Biotech: Internal Control Self-Evaluation Report
Haiwang Biotech: Special instructions on the elimination of internal control highlights in the first half of the 2024 fiscal year of Shenzhen Haiwang Biotechnology Co., Ltd. in this issue
Haiwang Biotech: Opinions of the Supervisory Board on the “Special Instructions of the Board of Directors on the 2023 Internal Control Audit Report with Unqualified Opinions on the Highlighted Sections and the Effects of Matters Involved in the Elimination of Implications”